|
MechanismCTLA4 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseIND Approval |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Suzhou Guokuang Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Suzhou Guokuang Pharmaceutical Technology Co., Ltd.
100 Deals associated with Suzhou Guokuang Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Suzhou Guokuang Pharmaceutical Technology Co., Ltd.